USA. Researchers Seek to Block Use of FDA-Approved OUD-Risk Test
USA. Researchers Seek to Block Use of FDA-Approved OUD-Risk Test
A group of researchers urged US regulators to revoke the approval of a test marketed for predicting risk for opioid addiction and said government health plans should not pay for the product.
The focus of the request is AdvertD (SOLVD Health), which the US Food and Drug Administration (FDA) approved in December as the first test to use DNA to evaluate if people have an elevated risk for opioid use disorder (OUD). A sample obtained through a cheek swab is meant to help guide decisions about opioid prescriptions for patients not previously treated with these drugs, such as someone undergoing a planned surgery, the FDA said. (Medscape, USA, 05.04.2024)
https://www.medscape.com/viewarticle/researchers-seek-block-use-fda-approved-oud-risk-test-2024a10006jm